Examining Anti-VEGF Biosimilars in the Management of Retinal Diseases

home / case-based-roundtable-series / examining-anti-vegf-biosimilars-in-the-management-of-retinal-diseases

Dilsher S. Dhoot, MD shares his experience leading a case-based roundtable discussion on anti-VEGF biosimilars for retinal diseases, highlighting key insights from each patient case.

EP. 1: Patient case 1: Neovascular AMD Patient Treated with Ranibizumab Biosimilar

Dilsher S. Dhoot, MD

February 14th 2024

Dilsher S. Dhoot, MD discusses a recent case-based roundtable meeting on anti-VEGF biosimilars, highlighting the first of two case discussions.

EP. 2: Patient case 2: DME Patient Treated with Ranibizumab Biosimilar

Dilsher S. Dhoot, MD

February 15th 2024

Dilsher S. Dhoot, MD discusses a recent case-based roundtable meeting on anti-VEGF biosimilars, highlighting the first of two case discussions.

Do Not Sell My Personal Information

Job Board

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777